Your browser doesn't support javascript.
loading
Selected recent advances in understanding the role of human mast cells in health and disease.
Levi-Schaffer, Francesca; Gibbs, Bernhard F; Hallgren, Jenny; Pucillo, Carlo; Redegeld, Frank; Siebenhaar, Frank; Vitte, Joana; Mezouar, Soraya; Michel, Moïse; Puzzovio, Pier Giorgio; Maurer, Marcus.
Afiliação
  • Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: francescal@ekmd.huji.ac.il.
  • Gibbs BF; Department of Human Medicine, University of Oldenburg, Oldenburg, Germany.
  • Hallgren J; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Pucillo C; Laboratory of Immunology, Department of Medicine, University of Udine, Udine, Italy.
  • Redegeld F; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
  • Siebenhaar F; Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP Allergology and Immunology, Berlin, Germany.
  • Vitte J; Aix-Marseille University, IRD, APHM, MEPHI, Marseille, France; IDESP, INSERM UA 11, Montpellier, France.
  • Mezouar S; Aix-Marseille University, IRD, MEPHI, Marseille, France.
  • Michel M; Aix-Marseille University, IRD, APHM, MEPHI, Marseille, France; Immunology Laboratory, CHU Nîmes, Nîmes, France.
  • Puzzovio PG; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Maurer M; Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP Allergology and Immunology, Berlin, Germany. Electronic address: m
J Allergy Clin Immunol ; 149(6): 1833-1844, 2022 06.
Article em En | MEDLINE | ID: mdl-35276243
ABSTRACT
Mast cells are highly granular tissue-resident cells and key drivers of inflammation, particularly in allergies as well as in other inflammatory diseases. Most mast cell research was initially conducted in rodents but has increasingly shifted to the human system, with the advancement of research technologies and methodologies. Today we can analyze primary human cells including rare subpopulations, we can produce and maintain mast cells isolated from human tissues, and there are several human mast cell lines. These tools have substantially facilitated our understanding of their role and function in different organs in both health and disease. We can now define more clearly where human mast cells originate from, how they develop, which mediators they store, produce de novo, and release, how they are activated and by which receptors, and which neighboring cells they interact with and by which mechanisms. Considerable progress has also been made regarding the potential contribution of mast cells to disease, which, in turn, has led to the development of novel approaches for preventing key pathogenic effects of mast cells, heralding the era of mast cell-targeted therapeutics. In this review, we present and discuss a selection of some of the most significant advancements and remaining gaps in our understanding of human mast cells during the last 25 years, with a focus on clinical relevance.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade / Mastócitos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade / Mastócitos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article